share_log

翰森製藥:發佈公司通訊之新安排

HANSOH PHARMA: NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS

香港交易所 ·  Mar 11 05:47
Summary by Moomoo AI
翰森製藥集團有限公司宣布,根據香港聯合交易所有限公司證券上市規則修訂後的規則,將於2024年3月11日起,改以電子通訊方式發送公司通訊給股東,並僅在股東要求下提供印刷本形式。公司通訊將包括董事會報告、財務報告等重要文件,並會在公司及聯交所網站公布。股東需提供有效的電子郵箱地址以接收通訊,若無有效郵箱地址,公司將按照股東的要求寄發印刷本。此外,股東可隨時向公司提出以印刷本形式接收公司通訊的要求。
翰森製藥集團有限公司宣布,根據香港聯合交易所有限公司證券上市規則修訂後的規則,將於2024年3月11日起,改以電子通訊方式發送公司通訊給股東,並僅在股東要求下提供印刷本形式。公司通訊將包括董事會報告、財務報告等重要文件,並會在公司及聯交所網站公布。股東需提供有效的電子郵箱地址以接收通訊,若無有效郵箱地址,公司將按照股東的要求寄發印刷本。此外,股東可隨時向公司提出以印刷本形式接收公司通訊的要求。
HANSEN PHARMACEUTICAL GROUP LIMITED ANNOUNCES THAT IT WILL SEND CORPORATE COMMUNICATIONS TO SHAREHOLDERS BY ELECTRONIC MEANS FROM 11 MARCH 2024 UNDER THE REVISED RULES OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED AND ONLY AVAILABLE IN PRINTED FORM AT THE SHAREHOLDER'S REQUEST. Corporate communications will include important documents such as board reports, financial reports, and will be published on the company's and exchange websites. Shareholders are required to provide a valid e-mail address to receive communications. If there is no valid e-mail address, the Company will send a printed copy at the request of the shareholder. In addition, shareholders may request the Company to receive the Company's communications in printed form at any time.
HANSEN PHARMACEUTICAL GROUP LIMITED ANNOUNCES THAT IT WILL SEND CORPORATE COMMUNICATIONS TO SHAREHOLDERS BY ELECTRONIC MEANS FROM 11 MARCH 2024 UNDER THE REVISED RULES OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED AND ONLY AVAILABLE IN PRINTED FORM AT THE SHAREHOLDER'S REQUEST. Corporate communications will include important documents such as board reports, financial reports, and will be published on the company's and exchange websites. Shareholders are required to provide a valid e-mail address to receive communications. If there is no valid e-mail address, the Company will send a printed copy at the request of the shareholder. In addition, shareholders may request the Company to receive the Company's communications in printed form at any time.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more